What you need to know:
1. For 2019, NuVasive reported $1.2 billion in revenue, an increase of 6 percent year over year.
2. The company reported an adjusted net income of $29.9 million on the quarter and $65.2 million on the year.
3. NuVasive issued 2020 revenue growth predictions of 4 percent to 6 percent, with adjusted earnings per share around $1.15 to $1.25.
4. NuVasive expects its international business and U.S. spinal hardware divisions to drive growth in 2020.
5. NuVasive CEO J. Christopher Barry said, “In 2020, our primary growth drivers include continuing to lead in lateral spine surgery, further innovation in targeted spine segments and achieving scale in key global markets to drive value and deliver on our long-term commitments.”
Read the entire financial report here.
More articles on devices:
4 spine, orthopedic surgeons jumping into politics in 2020
North Carolina spine practice, InteliChart partner to improve patient engagement
123-bed hospital acquires 1st spine robot in Bay Area — 3 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.